KeyBank National Association’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,496
Closed -$859K 1101
2022
Q3
$859K Buy
3,496
+399
+13% +$108K ﹤0.01% 481
2022
Q2
$767K Buy
3,097
+34
+1% +$9.18K ﹤0.01% 525
2022
Q1
$1.01M Sell
3,063
-2,283
-43% -$703K ﹤0.01% 505
2021
Q4
$1.92M Buy
5,346
+1,830
+52% +$618K 0.01% 408
2021
Q3
$1.15M Buy
3,516
+622
+21% +$211K 0.01% 515
2021
Q2
$903K Sell
2,894
-948
-25% -$291K ﹤0.01% 590
2021
Q1
$1.23M Buy
3,842
+352
+10% +$113K 0.01% 504
2020
Q4
$1.13M Sell
3,490
-70
-2% -$19.4K 0.01% 490
2020
Q3
$986K Sell
3,560
-1,156
-25% -$333K 0.01% 484
2020
Q2
$1.14M Buy
+4,716
New +$947K 0.01% 426
2019
Q4
Sell
-5,026
Closed -$894K 1038
2019
Q3
$894K Sell
5,026
-3,088
-38% -$668K 0.01% 535
2019
Q2
$2.11M Buy
8,114
+3,222
+66% +$855K 0.01% 356
2019
Q1
$1.4M Buy
4,892
+579
+13% +$192K 0.01% 427
2018
Q4
$1.4M Sell
4,313
-1,320
-23% -$459K 0.01% 407
2018
Q3
$2.53M Sell
5,633
-9,284
-62% -$3.66M 0.01% 317
2018
Q2
$6.1M Sell
14,917
-1,197
-7% -$434K 0.04% 233
2018
Q1
$4.69M Sell
16,114
-6,286
-28% -$1.59M 0.03% 262
2017
Q4
$4.2M Sell
22,400
-5,275
-19% -$985K 0.02% 265
2017
Q3
$4.67M Sell
27,675
-1,343
-5% -$203K 0.03% 258
2017
Q2
$4.16M Buy
29,018
+1,884
+7% +$253K 0.02% 266
2017
Q1
$3.4M Buy
27,134
+2,381
+10% +$276K 0.02% 291
2016
Q4
$2.79M Buy
24,753
+2,963
+14% +$343K 0.02% 314
2016
Q3
$2.8M Buy
21,790
+9,470
+77% +$1.13M 0.02% 309
2016
Q2
$1.35M Sell
12,320
-3,002
-20% -$299K 0.01% 438
2016
Q1
$1.45M Buy
15,322
+1,624
+12% +$137K 0.01% 428
2015
Q4
$1.24M Buy
13,698
+5,050
+58% +$429K 0.01% 497
2015
Q3
$802K Buy
+8,648
New +$762K 0.01% 646

Other funds holding ABMD

KeyBank National Association's ABMD Position: Q4 2022 in Review

KeyBank National Association sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,496 shares — an estimated $859K sold.

KeyBank National Association first reported a position in ABMD in Q3 2015 and held it in 27 quarters. The position peaked at $6.1M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • KeyBank National Association reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • KeyBank National Association sold 3,496 Abiomed Inc shares in Q4 2022, an estimated $859K.
  • KeyBank National Association first reported a position in Abiomed Inc in Q3 2015 and held it in 27 quarters.
  • KeyBank National Association's Abiomed Inc position peaked at $6.1M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on KeyBank National Association's 13F filing for Q4 2022, filed 31 Jan 2023.